Xilio Therapeutics Inc. (XLO)
undefined
undefined%
At close: undefined
1.00
1.94%
After-hours Dec 13, 2024, 07:50 PM EST

Xilio Therapeutics Inc. Forcast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for XLO stock have an median target of 4, with a low estimate of 4 and a high estimate of 4. The median target predicts an increase of 308.16% from the current stock price of 0.98.

Analyst Consensus: Buy
Target Low Average Median High
Price $4 $4 $4 $4
Change 308.16% 308.16% 308.16% 308.16%

AI Analyst Report

According to 1 stock analyst, the rating for Xilio Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Nov 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
6.65M
from 0
Increased by -%
Revenue Next Year
32.73M
from 6.65M
Increased by 392.1%
EPS This Year
-1.26
from -2.78
Increased by 54.7%
EPS Next Year
-0.42
from -1.26
Increased by 66.7%